N
ISEE

Nuveen’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Nuveen’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,015,026
Closed -$39.9M – 3275
2023
Q2 		$39.9M Sell
1,015,026
-172,312
-15% -$6.08M 0.01% 667
2023
Q1 		$28.9M Sell
1,187,338
-369,955
-24% -$8.1M 0.01% 807
2022
Q4 		$33.3M Buy
1,557,293
+133,638
+9% +$2.85M 0.01% 732
2022
Q3 		$25.5M Buy
1,423,655
+397,709
+39% +$5.22M 0.01% 873
2022
Q2 		$9.87M Buy
1,025,946
+237,825
+30% +$2.99M ﹤0.01% 1521
2022
Q1 		$12.4M Buy
788,121
+7,503
+1% +$111K ﹤0.01% 1510
2021
Q4 		$6.78M Sell
780,618
-23,353
-3% -$383K ﹤0.01% 1923
2021
Q3 		$6.99M Buy
803,971
+463,725
+136% +$5.05M ﹤0.01% 2029
2021
Q2 		$2.15M Sell
340,246
-432,156
-56% -$2.79M ﹤0.01% 2678
2021
Q1 		$4.77M Sell
772,402
-238,354
-24% -$1.45M ﹤0.01% 2192
2020
Q4 		$6.98M Buy
1,010,756
+629,507
+165% +$4.03M ﹤0.01% 1903
2020
Q3 		$2.15M Buy
381,249
+167,011
+78% +$796K ﹤0.01% 2347
2020
Q2 		$1.09M Buy
+214,238
New +$893K ﹤0.01% 2589

Nuveen's ISEE Position: Q3 2023 in Review

Nuveen sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,015,026 shares — an estimated $39.9M sold.

Nuveen first reported a position in ISEE in Q2 2020 and held it in 13 quarters. The position peaked at $39.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Nuveen reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Nuveen sold 1,015,026 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $39.9M.
  • Nuveen first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • Nuveen's IVERIC bio, Inc. Common Stock position peaked at $39.9M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Nuveen's 13F filing for Q3 2023, filed 14 Nov 2023.